Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.8 USD | +5.35% | +15.34% | -15.61% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.61% | 15.06B | |
-2.01% | 104B | |
+1.85% | 97.42B | |
+0.79% | 22.2B | |
-17.66% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
+4.03% | 13.98B | |
+34.88% | 11.66B | |
-26.12% | 8.22B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene Lymphocytic Leukemia Treatment Shows Efficacy in Phase 3 Trial